Search
Rapport Therapeutics Inc
RAPPAdd to Watchlist
39.390USD
-2.280-5.47%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.88BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Mon, May 11
Updated: Mon, May 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Third Rock Ventures, LLC
15.48%
Fidelity Management & Research Company LLC
14.87%
ARCH Venture Partners
7.80%
Capital International Investors
7.11%
Cormorant Asset Management, LP
6.33%
Other
48.41%
Shareholders
Shareholders
Proportion
Third Rock Ventures, LLC
15.48%
Fidelity Management & Research Company LLC
14.87%
ARCH Venture Partners
7.80%
Capital International Investors
7.11%
Cormorant Asset Management, LP
6.33%
Other
48.41%
Shareholder Types
Shareholders
Proportion
Investment Advisor
44.45%
Venture Capital
31.60%
Investment Advisor/Hedge Fund
12.72%
Hedge Fund
12.70%
Individual Investor
4.65%
Research Firm
4.37%
Private Equity
1.41%
Bank and Trust
0.43%
Pension Fund
0.15%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
264
57.38M
119.98%
+6.40M
2025Q4
222
49.73M
104.33%
+9.58M
2025Q3
166
42.95M
90.12%
+1.16M
2025Q2
154
43.38M
118.86%
+3.70M
2025Q1
149
47.96M
131.36%
+9.87M
2024Q4
117
46.27M
126.51%
+9.23M
2024Q3
91
39.09M
106.87%
+12.18M
2024Q2
48
37.49M
102.49%
+37.49M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Third Rock Ventures, LLC
8.10M
17%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
6.92M
14.51%
+1.44M
+26.35%
Sep 30, 2025
ARCH Venture Partners
3.73M
7.82%
--
--
Sep 30, 2025
Capital International Investors
3.40M
7.14%
+800.00K
+30.74%
Sep 30, 2025
Cormorant Asset Management, LP
3.19M
6.7%
+251.60K
+8.56%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.42M
2.97%
+354.67K
+33.41%
Sep 30, 2025
Sofinnova Investments, Inc
1.95M
4.09%
-48.02K
-2.41%
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.63M
3.43%
+397.43K
+32.18%
Sep 30, 2025
Johnson & Johnson Innovation-JJDC, Inc.
1.78M
3.74%
-713.53K
-28.56%
Sep 30, 2025
Baker Bros. Advisors LP
1.55M
3.25%
+997.00K
+181.24%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1.76%
iShares Neuroscience and Healthcare ETF
0.84%
ALPS Medical Breakthroughs ETF
0.43%
Invesco Nasdaq Biotechnology ETF
0.1%
iShares Micro-Cap ETF
0.1%
ProShares Ultra Nasdaq Biotechnology
0.1%
Avantis US Small Cap Equity ETF
0.06%
iShares Biotechnology ETF
0.06%
Vanguard US Momentum Factor ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.76%
iShares Neuroscience and Healthcare ETF
Proportion0.84%
ALPS Medical Breakthroughs ETF
Proportion0.43%
Invesco Nasdaq Biotechnology ETF
Proportion0.1%
iShares Micro-Cap ETF
Proportion0.1%
ProShares Ultra Nasdaq Biotechnology
Proportion0.1%
Avantis US Small Cap Equity ETF
Proportion0.06%
iShares Biotechnology ETF
Proportion0.06%
Vanguard US Momentum Factor ETF
Proportion0.04%
iShares Russell 2000 Value ETF
Proportion0.03%